Stock KYTHERA BIOPHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Kythera Biopharmaceuticals Inc Stock

Equities

US5015701056

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Kythera Biopharmaceuticals Inc
2015 Allergan : forecasts second-half revenue above $8 billion RE

Latest news about Kythera Biopharmaceuticals Inc

Allergan : forecasts second-half revenue above $8 billion RE
More news

Press releases Kythera Biopharmaceuticals Inc

Kythera Biopharmaceuticals : Allergan Successfully Completes Kythera Acquisition; Adds Game-Changing KYBELLA Treatment for Double-Chin PU
Kythera Biopharmaceuticals : ® Biopharmaceuticals Submits Investigational New Drug Application for KYTH-105 to Treat Androgenetic Alopecia, or Male Pattern Hair Loss PU
KYTHERA(R) Biopharmaceuticals Submits Investigational New Drug Application for KYTH-105 to Treat Androgenetic Alopecia, or Male Pattern Hair Loss GL
KYTHERA(R) Biopharmaceuticals Submits Marketing Authorization Application in the European Union for ATX-101 as First-in-Class Treatment for the Reduction of Submental Fat GL
KYTHERA Biopharmaceuticals Releases Second Quarter 2015 Operating Results and Progress Update GL
More press releases

News in other languages on Kythera Biopharmaceuticals Inc

Allergan : Rassurée par la Fed, Wall Street finit dans le vert
Wall Street attendue en timide hausse avant la Fed
Adobe Systems : Les valeurs à suivre à Wall Street
Allergan : achète la biotech Kythera pour 2,1 milliards de dollars
More news

Managers and Directors - Kythera Biopharmaceuticals Inc

Managers TitleAgeSince
Ambrose Bailey PSD
 President 60 15-09-30
Maria Hilado BRD
 Director/Board Member 59 15-09-30
Jere D. Fellmann PRN
 Corporate Officer/Principal 72 12-05-31
Members of the board TitleAgeSince
Maria Hilado BRD
 Director/Board Member 59 15-09-30
Ambrose Bailey PSD
 President 60 15-09-30
Steven Fagien BRD
 Director/Board Member - -
More insiders

Company Profile

More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.26% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+1.41% 95.71B
ARGENX SE Stock argenx SE
+1.05% 22.02B
BIONTECH SE Stock BioNTech SE
-17.84% 20.9B
GENMAB A/S Stock Genmab A/S
-9.35% 17.85B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-42.83% 16.21B
BEIGENE, LTD. Stock BeiGene, Ltd.
-17.63% 15.52B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+4.55% 13.86B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+32.11% 12.04B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock